Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation?

T Burnouf, D Strunk, MBC Koh, K Schallmoser - Biomaterials, 2016 - Elsevier
The essential physiological role of platelets in wound healing and tissue repair builds the
rationale for the use of human platelet derivatives in regenerative medicine. Abundant …

Indications for and adverse effects of red-cell transfusion

JL Carson, DJ Triulzi, PM Ness - New England Journal of …, 2017 - Mass Medical Soc
Indications for and Adverse Effects of Red-Cell Transfusion | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

[HTML][HTML] Bacterial contamination of platelets for transfusion: strategies for prevention

JH Levy, MD Neal, JH Herman - Critical Care, 2018 - Springer
Platelet transfusions carry greater risks of infection, sepsis, and death than any other blood
product, owing primarily to bacterial contamination. Many patients may be at particular risk …

[PDF][PDF] Guidelines on the use of irradiated blood components

T Foukaneli, P Kerr, PHB Bolton-Maggs… - Br J …, 2020 - medi-guide.meditool.cn
Purpose To provide healthcare professionals with clear guidance on situations when the
use of irradiated blood components is indicated. The term 'blood component'means the …

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment

SD Keil, I Ragan, S Yonemura, L Hartson… - Vox …, 2020 - Wiley Online Library
Background and Objective Severe acute respiratory distress syndrome coronavirus‐2
(SARS‐CoV‐2), the causative agent of coronavirus disease 2019 (COVID‐19), is a member …

Challenges in the management of the blood supply

LM Williamson, DV Devine - The Lancet, 2013 - thelancet.com
Although blood suppliers are seeing short-term reductions in blood demand as a result of
initiatives in patient blood management, modelling suggests that during the next 5–10 years …

Pathogen inactivation technologies for cellular blood components: an update

P Schlenke - Transfusion Medicine and Hemotherapy, 2014 - karger.com
Nowadays patients receiving blood components are exposed to much less transfusion-
transmitted infectious diseases than three decades before when among others HIV was …

Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & …

K Bieback, B Fernandez-Munoz, S Pati, R Schäfer - Cytotherapy, 2019 - Elsevier
Fetal bovine serum (FBS) is used as a growth supplement in a wide range of cell culture
applications for cell-based research and therapy. However, as a xenogenic product, FBS …

[HTML][HTML] The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates

J Kaiser-Guignard, G Canellini, N Lion, M Abonnenc… - Blood reviews, 2014 - Elsevier
Since 1990, several techniques have been developed to photochemically inactivate
pathogens in platelet concentrates, potentially leading to safer transfusion therapy. The …

The safety of the blood supply—time to raise the bar

EL Snyder, SL Stramer… - New England Journal of …, 2015 - Mass Medical Soc
The Safety of the Blood Supply — Time to Raise the Bar | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …